Multimorbidity: another key issue for cardiovascular medicine

The Lancet

Volumn 374, Issue 9699, 2009, Pages 1421-1422

  Glynn, Liam G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; LETTER; MICROALBUMINURIA; MORBIDITY; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 70350102123     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61863-8     Document Type: Letter

References (5)

1. Jackson C.E., Solomon S.D., Gerstein H.C., et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 374 (2009) 543-550
2. Fortin M., Bravo G., Hudon C., Vanasse A., and Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 3 (2005) 223-228
3. The Lancet. Heart disease: breaking down barriers. Lancet 374 (2009) 501
4. Fortin M., Dionne J., Pinho G., Gignac J., Almirall J., and Lapointe L. Randomized controlled trials: do they have external validity for patients with multiple comorbidities?. Ann Fam Med 4 (2006) 104-108
5. Glynn L.G., Reddan D., Newell J., Buckley B., Dinneen S., and Murphy A.W. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br J General Practice 58 (2008) 488-494